Skip to main content

Table 2 Surrogate participation

From: Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)

 

Immediate

Deferred

All participants

Patients

17

19

36 (100%)

Surrogate named in ACP document

10

7

17 (47.2%)

Participated in ACP process

7

3

10 (27.8%)

Did not participate in ACP

3

4

7 (19.4%)

Convergeda

3

0

3 (8.3%)

No convergence

4

3

7 (19.4%)

  1. aConverged = surrogate’s understanding of ACP converged with patient’s on at least one dimension of ACP